HDR brachytherapy boost using MR-only workflow for intermediate- and high-risk prostate cancer: 8-year results of a pilot study

To report 8-year clinical outcome with high-dose-rate brachytherapy (HDRBT) boost using MRI-only workflow for intermediate (IR) and high-risk (HR) prostate cancer (PC) patients.

Source: Brachytherapy - January 18, 2021 Category: Cancer & Oncology Authors: Ferenc Lakosi, Gergely Antal, Janos Pall, Andrea Farkas, Tibor Jenei, Denes Nagy, Jozsef Liptak, Istvan Sipocz, Akos Pytel, Melinda Csima, Akos Gulyban, Gabor Toller Source Type: research